| Authors: |
McCorvie TJ; Centre for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.; Biosciences Institute, The Medical School, Newcastle University, Newcastle upon Tyne, UK., Loria PM; Discovery Sciences, Worldwide Research and Development, Pfizer Inc., Groton, CT, USA., Tu M; Medicine Design, Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA., Han S; Discovery Sciences, Worldwide Research and Development, Pfizer Inc., Groton, CT, USA., Shrestha L; Centre for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Froese DS; Centre for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.; Division of Metabolism and Children's Research Center, University Children's Hospital Zürich, University of Zürich, Zürich, Switzerland., Ferreira IM; Centre for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK., Berg AP; Rare Disease Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA. allison.berg@pfizer.com., Yue WW; Centre for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK. wyatt.yue@cmd.ox.ac.uk.; Biosciences Institute, The Medical School, Newcastle University, Newcastle upon Tyne, UK. wyatt.yue@cmd.ox.ac.uk. |
